Table 4.
Cytokine | Pre-LT |
1 month post-LT |
6 months post-LT |
1 year post-LT |
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Group 1, non-transfused | Group 2, transfused | P-value | Group 1, non-transfused | Group 2, transfused | P-value | Group 1, non-transfused | Group 2, transfused | P-value | Group 1, non-transfused | Group 2, transfused | P-value | |
IL-17, pg/ml | 64.3 ± 11.2 | 70.2 ± 20.2 | 0.10 | 13.4 ± 8.71 | 44.1 ± 11.5 | 0.03 | 24.5 ± 15.6 | 88.9 ± 20.1 | 0.014 | 33.3 ± 5.5 | 100.3 ± 22.2 | 0.011 |
IL-1β, pg/ml | 45.4 ± 16.1 | 40.5 ± 15.3 | 0.22 | 10.2 ± 7.33 | 40.4 ± 7.9 | 0.01 | 34.5 ± 9.3 | 70.5 ± 6.5 | 0.00 | 29.4 ± 11.1 | 88.3 ± 18.5 | 0.002 |
IL-6, pg/ml | 50.4 ± 14.9 | 60.1 ± 21.5 | 0.54 | 12.1 ± 6.21 | 64.3 ± 11.3 | 0.01 | 27.5 ± 13.8 | 80.1 ± 20.1 | 0.009 | 30.3 ± 9.9 | 94.4 ± 25.3 | 0.005 |
IL-4, pg/ml | 70.1 ± 17.3 | 79.5 ± 16.4 | 0.44 | 43.2 ± 10.5 | 98.5 ± 20.1 | 0.02 | 39.3 ± 8.1 | 120.3 ± 17.9 | 0.003 | 44.8 ± 13.9 | 111.3 ± 12.2 | 0.002 |
IL-5, pg/ml | 55.6 ± 20.2 | 70.9 ± 28.4 | 0.21 | 15.3 ± 4.4 | 52.2 ± 11.6 | 0.02 | 50.6 ± 20.3 | 89.4 ± 18.9 | 0.010 | 55.5 ± 25.2 | 100.3 ± 21.7 | 0.020 |
IL-10, pg/ml | 47.9 ± 11.4 | 54.3 ± 17.7 | 0.69 | 13.3 ± 6.5 | 39.2 ± 10.1 | 0.03 | 40.5 ± 4.9 | 68.8 ± 5.7 | 0.040 | 44.5 ± 18.3 | 74.3 ± 19.2 | 0.010 |
IFN-γ, pg/ml | 20.4 ± 5.6 | 19.9 ± 6.1 | 0.8 | 95.3 ± 17.7 | 45.6 ± 18.9 | 0.01 | 124.9 ± 29.4 | 30.1 ± 10.3 | 0.001 | 100.9 ± 8.0 | 23.1 ± 11.2 | 0.001 |
TGF-β, pg/ml | 145.7 ± 21.9 | 120.3 ± 24.3 | 0.32 | 24.5 ± 3.7 | 60.5 ± 11.9 | 0.009 | 40.5 ± 18.9 | 166.4 ± 31.4 | 0.002 | 50.3 ± 23.4 | 188.9 ± 31.5 | 0.005 |
IL, interleukin; IFN, interferon; TGF, transforming growth factor.